Sign in
4/A

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-029049

Chief Medical Officer sold 36,912 shares at an average $25.44 ($938,976)

  • Chief Medical Officer acquired 17,879 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2019-04-01 Option exercise +5,775 $5.28 $30,492 5,775 D
Ho Carole Chief Medical Officer 2019-04-01 Sale −5,775 $23.91 $138,080 0 D
Ho Carole Chief Medical Officer 2019-04-02 Option exercise +6,242 $5.28 $32,958 6,242 D
Ho Carole Chief Medical Officer 2019-04-02 Sale −2,800 $24.51 $68,628 3,442 D
Ho Carole Chief Medical Officer 2019-04-02 Sale −3,442 $25.15 $86,566 0 D
Ho Carole Chief Medical Officer 2019-04-02 Sale −9,445 $25.29 $238,864 132,670 I
Ho Carole Chief Medical Officer 2019-04-03 Option exercise +5,862 $5.28 $30,951 5,862 D
Ho Carole Chief Medical Officer 2019-04-03 Sale −5,262 $26.27 $138,233 600 D
Ho Carole Chief Medical Officer 2019-04-03 Sale −600 $26.81 $16,086 0 D
Ho Carole Chief Medical Officer 2019-04-03 Sale −8,688 $26.29 $228,408 123,982 I
Ho Carole Chief Medical Officer 2019-04-03 Sale −900 $26.79 $24,111 123,082 I
Derivatives
Ho Carole Chief Medical Officer 2019-04-01 Option exercise · Stock Option (right to buy) −5,775 105,855 D
Ho Carole Chief Medical Officer 2019-04-02 Option exercise · Stock Option (right to buy) −6,242 99,613 D
Ho Carole Chief Medical Officer 2019-04-03 Option exercise · Stock Option (right to buy) −5,862 93,751 D
Open-market sales · 36,912 sh · avg $25.44 · $938,976
Loading xslF345X03/doc4a.xml…